Molnupiravir was created after years of research to treat severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS). CONTRIBUTED PHOTOA promising new pill that aims to cure patients with moderate and severe Covid-19 symptoms is now undergoing clinical trials in the country. Molnupiravir was created after years of research to treat severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS). Tamesis said another trial would be held to determine if the pill could prevent further transmission of the virus to other people. The president of the Pharmaceutical and Healthcare Association of the Philippines said that while molnupiravir may help severe Covid-19 infection, an effective Covid-19 prevention strategy remained crucial.

Source: Manila Times October 09, 2021 13:52 UTC